MedTrace Logo

Vitamin D and Painful Diabetic Neuropathy

NCT05080530 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2022-07-21

No results posted yet for this study

Summary

The main objective of this study is to evaluate the effect of vitamin D3 on diabetic individual with painful neuropathy in a tertiary healthcare.

The people with diabetes (type 1 and type 2) who have a Douleur Neuropathique 4 (DN4) score ≥4 will be considered eligible in this prospective study. Their serum samples will be subjected to pre-and post-biochemical screening of serum 25 (OH) D and HbA1c. The individual having Vitamin D insufficiency and deficiency will be administered a single dose of oral Vitamin D3 (Soft Gel capsule 200,000 IU), and follow-up for post-biochemical screening after 3 months.

Conditions

  • Painful Diabetic Neuropathy

Interventions

DRUG

Cholecalciferol

Effect of Vitamin D on diabetic neuropathy symptoms

Sponsors & Collaborators

  • Scotmann Pharmaceuticals

    collaborator INDUSTRY

  • Baqai Institute of Diabetology and Endocrinology

    lead OTHER

Principal Investigators

  • Abdul Basit, Director · Baqai Institute of Diabetology and Endocrinology (BIDE)

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-29
Primary Completion
2022-08-20
Completion
2022-08-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080530 on ClinicalTrials.gov